# Xerava

NDC: 71773-100
Generic name: eravacycline
Labeler / Manufacturer: Tetraphase Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20180910

FDA application: NDA211109

## Active ingredients

- ERAVACYCLINE DIHYDROCHLORIDE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71773-100"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71773-100
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a4b188d4-f467-470c-ad7b-25ffbdd8862a